In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus andFusarium Isolates

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2001-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.45.1.327-330.2001PMID 11120990PMCID PMC90285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods.

  1999cited by this paper
• In Vitro Susceptibilities of Candida dubliniensisIsolates Tested against the New Triazole and Echinocandin Antifungal Agents

  1999cited by this paper
• Microdilution Susceptibility Testing of Amphotericin B, Itraconazole, and Voriconazole against Clinical Isolates of Aspergillus and FusariumSpecies

  1999cited by this paper
• In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.

  1998cited by this paper
• Evaluation of Endpoints for Antifungal Susceptibility Determinations with LY303366

  1998influential reference
• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

  1998cited by this paper
• Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro

  1997cited by this paper
• In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species

  1997cited by this paper
• Growth medium effect on the antifungal activity of LY 303366.

  1997influential reference
• Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans

  1997cited by this paper
• In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds

  1997cited by this paper
• Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

  1997cited by this paper
• In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents

  1997cited by this paper
• Echinocandins and pneumocandins--a new antifungal class with a novel mode of action.

  1997cited by this paper
• Treatment of murine disseminated candidiasis with L-743,872

  1997cited by this paper
• Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.

  1997cited by this paper
• In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species

  1997cited by this paper
• In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

  1997influential reference
• In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates

  1997cited by this paper
• In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions.

  1997cited by this paper
• In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates

  1996cited by this paper
• Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.

  1996cited by this paper
• detect amphotericin B-resistant Candida susceptibility testing : enhanced ability to macrodilution method for antifungal for Clinical Laboratory Standards broth Comparison of Etest and National Committee

  1995cited by this paper
• Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

  1995cited by this paper
• Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

  1994cited by this paper
• Morphological Effects of Lipopeptides against Aspergillus fumigatus Correlate with Activities against (1,3)-β-d-Glucan Synthase

  1994influential reference
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• In vitro activity of novel antifungals, natamycin, and terbinafine against Fusarium

  2025cites this paper
• Evaluation of the Antifungal Activity of Fluconazole Nanovesicles Against Aspergillus fumigatus

  2024cites this paper
• Opportunities and challenges of RiPP-based therapeutics.

  2024cites this paper
• Fusariosis en pacientes con cáncer: serie de 13 casos y revisión de la literatura

  2023cites this paper
• Antifungal Susceptibility of Yeasts and Filamentous Fungi by CLSI Broth Microdilution Testing.

  2023cites this paper
• Insecticidal and antifungal activities of Melaleuca rhaphiophylla essential oil against insects and seed-borne pathogens in stored products

  2022cites this paper
• Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents

  2022cites this paper
• Antifungal Susceptibility Testing: A Primer for Clinicians

  2021cites this paper
• The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

  2021cites this paper
• Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates In Vitro Activity against Members of the Fusarium oxysporum and Fusarium solani Species Complexes

  2021cites this paper
• Uncommon Yeasts and Molds Causing Human Disease

  2020cites this paper
• Review: Feed residues of glyphosate - potential consequences for livestock health and productivity.

  2020cites this paper
• Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran

  2020cites this paper
• Drain outlets in patient rooms as sources for invasive fusariosis: an analysis of patients with haematological disorders.

  2020cites this paper
• Synthesis, Characterization and Antifungal Activity of Fe(III) Metal–Organic Framework and its Nano-composite

  2019cites this paper
• APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental Coccidioides immitis Pneumonia

  2018cites this paper
• In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi.

  2018cites this paper
• Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus

  2017cites this paper
• Fusarium Keratitis in Germany

  2017cites this paper
• Echinocandins in Ocular Therapeutics

  2017cites this paper
• Use of Novel Tools to Probe Drug Resistance in Fungi

  2017cites this paper
• Echinocandins in antifungal pharmacotherapy

  2017cites this paper
• Combinatorial strategies for combating invasive fungal infections

  2017cites this paper
• Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.

  2016cites this paper
• Infección por Fusarium en pacientes oncológicos

  2016cites this paper
• Engineering of New Pneumocandin Side-Chain Analogues from Glarea lozoyensis by Mutasynthesis and Evaluation of Their Antifungal Activity.

  2016cites this paper
• Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature

  2016cites this paper
• Echinocandins: The Expanding Antifungal Armamentarium.

  2015cites this paper
• Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies

  2015cites this paper
• Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111

  2015cites this paper
• Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae

  2015cites this paper
• Isolation and characterization of an antimicrobial lipopeptide produced by Paenibacillus ehimensis MA2012

  2015cites this paper
• Treatment of Aspergillus terreus infections: a clinical problem not yet resolved.

  2014cites this paper
• Echinocandins: production and applications

  2013cites this paper
• The pharmacodynamics of antifungal agents against Aspergillus

  2013influential citation
• Caspofungin

  2012cites this paper
• Newer Systemic Antifungal Agents

  2012cites this paper
• Comparison between Alcoholic Eucalyptus and Nano-silver as a New Nanocomposition in Growth Inhibition of Aspergilus Niger

  2012cites this paper
• The echinocandin B producer fungus Aspergillus nidulans var. roseus ATCC 58397 does not possess innate resistance against its lipopeptide antimycotic

  2012cites this paper
• Comparison of Nanosilver Inhibitory Effects Growth between Aspergillus niger and E. coli

  2012cites this paper
• In vitro susceptibility of aflatoxigenic and non-aflatoxigenic Aspergillus flavus strains to conventional antifungal agents.

  2012cites this paper
• In Vitro Combination of Anidulafungin and Voriconazole against Intrinsically Azole-Susceptible and -Resistant Aspergillus spp

  2012cites this paper
• Identification problems with sterile fungi, illustrated by a keratitis due to a non-sporulating Chaetomium-like species.

  2012cites this paper
• Caspofungin

  2012cites this paper
• Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in an In Vitro Model of Invasive Pulmonary Aspergillosis

  2012cites this paper
• In Vitro Activity of Calcineurin and Heat Shock Protein 90 Inhibitors against Aspergillus fumigatus Azole- and Echinocandin-Resistant Strains

  2012cites this paper
• Synthesis -1,3-Glucan β Activity of Inhibitors of Aspergillus fumigatus and the Antifungal -1,3-Glucan Metabolism of β Influences the The Composition of the Culture Medium

  2012cites this paper
• The Composition of the Culture Medium Influences the β-1,3-Glucan Metabolism of Aspergillus fumigatus and the Antifungal Activity of Inhibitors of β-1,3-Glucan Synthesis

  2012cites this paper
• Biocontrol of the soil borne rhizosphere associated Fu s ariu m sp. of Mu s a sp. with T ric h o d e rm a v irid e Pers.

  2011cites this paper
• Combined Therapy of Voriconazole and Anidulafungin in Murine Infections by Aspergillus flavus

  2011cites this paper
• Can We Achieve Clinical Breakpoints for the Triazoles in Aspergillosis?

  2011cites this paper
• Hyalohyphomycoses (Hyaline Moulds)

  2011cites this paper
• Resistance to Antifungal Drugs

  2011cites this paper
• Fusarium and Other Opportunistic Hyaline Fungi

  2011cites this paper
• The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.

  2011cites this paper
• Antifungal Testing and High-Throughput Screening of Compound Library against Geomyces destructans, the Etiologic Agent of Geomycosis (WNS) in Bats

  2011cites this paper
• Impact of land use on distribution and diversity of fusarium species in ngangao forest, Taita Taveta District in Kenya and the adjacent farmlands

  2011cites this paper
• Antifungal Susceptibility Tests

  2011cites this paper
• Emerging moulds: epidemiological trends and antifungal resistance

  2011cites this paper
• Checklist of Fusarium Species Reported from Turkey

  2011cites this paper
• In vitro susceptibility testing in Aspergillus species: an update.

  2010cites this paper
• Resistance to Antifungal Agents

  2010cites this paper
• In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus.

  2010cites this paper
• The Antibiotic Properties of Several Strains of Fungi

  2010cites this paper
• Development of a nested PCR assay for the detection of Fusarium solani DNA and its evaluation in the diagnosis of invasive fusariosis using an experimental mouse model

  2010cites this paper
• Aspergillus alliaceus and Aspergillus flavus co-infection in an acute myeloid leukemia patient.

  2010cites this paper
• Antifungal Susceptibility Profile of Human-Pathogenic Species of Lichtheimia

  2010cites this paper
• Using Antifungal Pharmacodynamics to Improve Patient Outcomes

  2010cites this paper
• In vitro susceptibility testing in fungi: a global perspective on a variety of methods

  2010cites this paper
• Morphological changes of Fusariumoxysporum induced by CF66I, an antifungal compound from Burkholderia cepacia

  2010cites this paper
• Fungal echinocandin resistance

  2010cites this paper
• New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance

  2009cites this paper
• Fusarium species detected in onychomycosis in Colombia

  2009cites this paper
• Disseminated Geosmithia argillacea infection in a German shepherd dog.

  2009cites this paper
• ANTAGONISMO IN VITRO DE Trichoderma harzianum Rifai SOBRE Fusarium oxysporum Schlecht f. sp passiflorae EN MARACUYÁ (Passiflora edulis Sims var. Flavicarpa) DEL MUNICIPIO ZONA BANANERA COLOMBIANA

  2009cites this paper
• Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.

  2009cites this paper
• Micafungin in the treatment of invasive candidiasis and invasive aspergillosis

  2009cites this paper
• Caspofungin Etest Endpoint for Aspergillus Isolates Shows Poor Agreement with the Reference Minimum Effective Concentration

  2009cites this paper
• Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination

  2009cites this paper
• Trends in antifungal susceptibility testing using CLSI reference and commercial methods

  2009cites this paper
• Fungal Drug Resistance Assays

  2009cites this paper
• Spectroscopic study of molecular structures of novel Schiff base derived from o-phthaldehyde and 2-aminophenol and its coordination compounds together with their biological activity.

  2009cites this paper
• Infections due to Phialemonium species: case report and review.

  2009cites this paper
• Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing

  2008cites this paper
• Issues in antifungal susceptibility testing.

  2008cites this paper
• In vitro susceptibility‐testing in Aspergillus species

  2008cites this paper
• Pulmonary Phialemonium curvatum phaeohyphomycosis in a Standard Poodle dog.

  2008cites this paper
• Actividad in vitro de anidulafungina. Comparación con la actividad de otras equinocandinas

  2008cites this paper
• Diagnostic value of DNA and (1-->3)- beta-D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum.

  2008cites this paper
• Susceptibility Testing and Molecular Classification of Paecilomyces spp

  2008cites this paper
• [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].

  2008cites this paper
• Susceptibility Testing of Anidulafungin and Voriconazole Alone and in Combination against Conidia and Hyphae of Aspergillus spp. under Hypoxic Conditions

  2008cites this paper
• In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents

  2007cites this paper
• Caspofungine et mycoses à champignons rares : activité in vitro et in vivo chez l’animal et chez l’homme

  2007cites this paper
• Mucor rouxii Rho1 protein; characterization and possible role in polarized growth

  2007cites this paper
• The use of caspofungin in HIV-infected individuals

  2007cites this paper
• Effect of Caspofungin on Metabolite Profiles of Aspergillus Species Determined by Nuclear Magnetic Resonance Spectroscopy

  2007cites this paper
• [Infection caused by Fusarium species in non-neutropenic oncological patients].

  2007cites this paper
• Infección por Fusarium en pacientes oncológicos no neutropénicos

  2007cites this paper
• Filamentous Fungi in a Tertiary Care Hospital Environmental Surveillance and Susceptibility to Antifungal Drugs

  2007cites this paper